Spontaneous bacterial peritonitis caused by quinolone-resistant Escherichia coli: Could steroid therapy play a role?

European Journal of Gastroenterology and Hepatology

Volumn 14, Issue 1, 2002, Pages 81-83

  Cereto, Ferran ^a   Genescà, Joan ^a   Smithson, Alex ^a   González, Antonio ^a   Moreno, Gina ^a   Del Valle Ortiz, Oscar ^a   Esteban, Rafael ^a   Guardia, Jaime ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Liver cirrhosis; Quinolone resistant E. coli; Selective intestinal decontamination; Spontaneous bacterial peritonitis; Steroid therapy

Indexed keywords

AMPICILLIN; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN; CORTICOSTEROID; COTRIMOXAZOLE; NORFLOXACIN; PREDNISONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL PERITONITIS; CASE REPORT; DISEASE ASSOCIATION; ESCHERICHIA COLI; FEMALE; HUMAN; INFECTION RISK; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; STEROID THERAPY; STRAIN DIFFERENCE; THERAPY RESISTANCE;

AGED; ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FATAL OUTCOME; FEMALE; GLUCOCORTICOIDS; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NORFLOXACIN; PERITONITIS; PREDNISONE;

EID: 0036155118     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200201000-00014     Document Type: Article

References (14)

1. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis a consensus document
2. Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis: Effect of long-term administration of norfloxacin
3. Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis
4. Emergence of quinolone-resistant Escherichia coli bacteremia in neutropenic patients with cancer who have received prophylactic norfloxacin
5. Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis
6. Development of quinolone-resistant strains of Escherichia coli on stools of patients with cirrhosis undergoing norfloxacin prophylaxis: Clinical consequences
7. Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination
8. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin
9. Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients
10. Spontaneous bacterial peritonitis and empyema by Escherichia coli resistant to norfloxacine in a patient on selective decontamination with norfloxacine
11. Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites
12. Invasive disease caused by ciprofloxacin-resistant uropathogenic Escherichia coli
13. Translocación bacteriana intestinal
14. Escherichia coli: Epidemiology and analysis of risk factors for infections caused by resistant strains